BNP Paribas Financial Markets’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

BNP Paribas Financial Markets’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-515	Closed	-$4.36K	–	3774
2015 Q1	$4.36K	Buy	+515	New	+$4.39K	﹤0.01%	3229
2014 Q4	–	Sell	-1,663	Closed	-$13.9K	–	4192
2014 Q3	$13.9K	Buy	1,663 +806	+94%	+$7.47K	﹤0.01%	3404
2014 Q2	$9.91K	Buy	857 +53	+7%	+$544	﹤0.01%	2369
2014 Q1	$8.31K	Buy	804 +36	+5%	+$465	﹤0.01%	2338
2013 Q4	$8.31K	Buy	+768	New	+$8.92K	﹤0.01%	2759

Other funds holding DSCI

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets's DSCI Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 515 shares — an estimated $4.36K sold.

BNP Paribas Financial Markets first reported a position in DSCI in Q4 2013 and held it in 5 quarters. The position peaked at $13.9K in Q3 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

BNP Paribas Financial Markets reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
BNP Paribas Financial Markets sold 515 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $4.36K.
BNP Paribas Financial Markets first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 5 quarters.
BNP Paribas Financial Markets's Derma Sciences, Inc. Common Stock (DE) position peaked at $13.9K in Q3 2014.
62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.